Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | beta-lactamase | 0.0074 | 0.06 | 0.1137 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0074 | 0.06 | 0.1137 |
Mycobacterium ulcerans | lipase LipD | 0.0074 | 0.06 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0259 | 0.4963 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0074 | 0.06 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0075 | 0.0628 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0074 | 0.06 | 0.0687 |
Onchocerca volvulus | 0.0177 | 0.3029 | 1 | |
Echinococcus granulosus | tumor protein p63 | 0.0396 | 0.8188 | 1 |
Brugia malayi | TAR-binding protein | 0.0259 | 0.4963 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0074 | 0.06 | 0.1208 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0074 | 0.06 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0075 | 0.0628 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0075 | 0.0628 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0074 | 0.06 | 0.1137 |
Brugia malayi | beta-lactamase | 0.0074 | 0.06 | 0.1208 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Schistosoma mansoni | tar DNA-binding protein | 0.0259 | 0.4963 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0109 | 0.1414 | 0.2849 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0221 | 0.0369 |
Onchocerca volvulus | 0.0074 | 0.06 | 0.1348 | |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0236 | 0.4414 | 0.5368 |
Mycobacterium ulcerans | beta-lactamase | 0.0074 | 0.06 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Echinococcus multilocularis | tar DNA binding protein | 0.0259 | 0.4963 | 0.6043 |
Onchocerca volvulus | 0.0074 | 0.06 | 0.1348 | |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0074 | 0.06 | 0.5 |
Onchocerca volvulus | 0.0074 | 0.06 | 0.1348 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0159 | 0.2599 | 0.5236 |
Echinococcus granulosus | tar DNA binding protein | 0.0259 | 0.4963 | 0.6043 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0159 | 0.2599 | 0.5197 |
Loa Loa (eye worm) | TAR-binding protein | 0.0259 | 0.4963 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0236 | 0.4414 | 0.8884 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0259 | 0.4963 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0074 | 0.06 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0058 | 0.0221 | 0.0369 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Schistosoma mansoni | tar DNA-binding protein | 0.0259 | 0.4963 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0074 | 0.06 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.005 | 0.004 | 0.008 |
Brugia malayi | hypothetical protein | 0.0177 | 0.3029 | 0.6102 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.0628 | 0.1196 |
Mycobacterium leprae | conserved hypothetical protein | 0.0074 | 0.06 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.2599 | 0.5197 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.3029 | 0.6071 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0075 | 0.0628 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0074 | 0.06 | 0.1137 |
Brugia malayi | RNA binding protein | 0.0259 | 0.4963 | 1 |
Brugia malayi | hypothetical protein | 0.0236 | 0.4414 | 0.8893 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0075 | 0.0628 | 1 |
Trichomonas vaginalis | esterase, putative | 0.0074 | 0.06 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Schistosoma mansoni | tar DNA-binding protein | 0.0259 | 0.4963 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.1414 | 0.2792 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0074 | 0.06 | 0.1208 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0074 | 0.06 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0075 | 0.0628 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0074 | 0.06 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0074 | 0.06 | 0.1208 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0075 | 0.0628 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0259 | 0.4963 | 1 |
Brugia malayi | hypothetical protein | 0.0075 | 0.0628 | 0.1266 |
Schistosoma mansoni | hypothetical protein | 0.0109 | 0.1414 | 0.2792 |
Brugia malayi | Latrophilin receptor protein 2 | 0.005 | 0.004 | 0.008 |
Echinococcus multilocularis | tumor protein p63 | 0.0396 | 0.8188 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0259 | 0.4963 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0259 | 0.4963 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0075 | 0.0628 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0159 | 0.2599 | 0.5236 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0074 | 0.06 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0074 | 0.06 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.06 | 0.1137 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0074 | 0.06 | 0.0687 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0236 | 0.4414 | 0.5368 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.